Loading…
Summit Therapeutics Inc. is projected to rise to $20.52 by 2027, a +35% move from its current price of $15.25. SMMT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $14.80 | $15.26 | $15.73 | +0.05% |
| Jul 14 | $14.62 | $15.27 | $15.94 | +0.11% |
| Jul 15 | $14.49 | $15.27 | $16.10 | +0.16% |
| Jul 16 | $14.38 | $15.28 | $16.24 | +0.21% |
| Jul 17 | $14.29 | $15.29 | $16.36 | +0.27% |
| Jul 18 | $14.20 | $15.30 | $16.48 | +0.32% |
| Jul 19 | $14.13 | $15.31 | $16.59 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.13 | $15.31 | $16.59 | +0.37% |
| Week 2 | $13.71 | $15.36 | $17.21 | +0.74% |
| Week 3 | $13.42 | $15.42 | $17.72 | +1.12% |
| Week 4 | $13.18 | $15.48 | $18.18 | +1.50% |
| Week 5 | $12.98 | $15.54 | $18.59 | +1.87% |
| Week 6 | $12.81 | $15.59 | $18.98 | +2.25% |
| Week 7 | $12.66 | $15.65 | $19.36 | +2.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Summit Therapeutics Inc. is a biopharmaceutical company focused on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC).
The company markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
Summit Therapeutics Inc. (SMMT) is trading at $15.42. The asset carries a market capitalization of $11.97B and is ranked 811 by size.
The forecast implies a multi-year uplift, with the 2026 average price at $15.42, rising to $28.42 by 2030, $96.98 by 2040, and $195.31 by 2050, with max values up to $43.50, $177.00, and $395.45 respectively.
Projected ROI grows from 0 in 2026 to 84.3 by 2030, 528.9 by 2040, and 1166.6 by 2050, with sentiment remaining bullish across the longer horizon.
A major floor 29.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.4% below — buyers have tended to step in here.
The nearest ceiling, 15.0% above — a clean break opens room to run.
A major ceiling 73.0% above — clearing it would confirm fresh momentum.
Key SMMT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SMMT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.65 | Sell | $15.40 | Sell |
| MA 10 | $15.09 | Buy | $15.18 | Buy |
| MA 20 | $14.54 | Buy | $15.06 | Buy |
| MA 50 | $15.96 | Sell | $15.85 | Sell |
| MA 100 | $17.05 | Sell | $16.70 | Sell |
| MA 200 | $17.60 | Sell | $17.66 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.50 | Neutral |
| Stoch RSI (14) | 60.58 | Neutral |
| CCI (20) | 73.49 | Neutral |
| Williams %R (14) | -35.42 | Info |
| MACD (12,26,9) | 0.28 | Buy |
| ROC (12) | 7.02 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 64.58 | Neutral |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | 0.62 | Buy |
| Ultimate (7,14,28) | 62.20 | Neutral |
| Momentum (10) | 1.07 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 15.78 | Sell |
| ADX (14) | 15.78 | Neutral |
| ATR (14) | 0.37 | Info |
The 30-day technical picture is BULLISH. RSI14 is 50; SMA50 is $16.64; SMA200 is $17.68.
Support sits at $13.05 and resistance at $17.89. The 30-day range spans $12.30 to $19.33, and annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.05 | $15.25 | $20.67 | 0% | Neutral | |
| $16.17 | $20.52 | $27.66 | +35% | Bullish | |
| $17.26 | $22.60 | $31.72 | +48% | Bullish | |
| $18.69 | $25.12 | $36.38 | +65% | Bullish | |
| $20.40 | $28.06 | $41.73 | +84% | Bullish | |
| $22.61 | $31.78 | $48.36 | +108% | Bullish | |
| $29.34 | $42.05 | $65.33 | +176% | Bullish | |
| $33.24 | $48.53 | $76.82 | +218% | Bullish | |
| $34.09 | $50.66 | $81.57 | +232% | Bullish | |
| $35.01 | $52.92 | $86.58 | +247% | Bullish | |
| $58.22 | $95.05 | $166.21 | +523% | Bullish | |
| $101.63 | $189.90 | $365.62 | +11.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.05 | $15.25 | $18.67 | +0.00% |
| August 2026 | $13.24 | $15.67 | $19.08 | +2.74% |
| September 2026 | $13.42 | $16.01 | $19.73 | +2.15% |
| October 2026 | $13.89 | $16.68 | $20.78 | +4.24% |
| November 2026 | $13.80 | $16.67 | $20.94 | -0.11% |
| December 2026 | $13.44 | $16.32 | $20.67 | -2.08% |
Click any year to see its month-by-month SMMT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Summit Therapeutics Inc.'s 2026 outlook centres on $15.25, within a $13.05 to $20.67 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SMMT could reach as high as $27.66, with a base case around $20.52 and support toward $16.17 — roughly +35% from $15.25. Buyers look set to stay in control over this stretch.
Expect SMMT to range from $17.26 to $31.72 through 2028. The $22.60 average target implies a +48% move from current prices. That is up +10% on the projected 2027 average. Momentum favours further upside here.
The SMMT price prediction for 2029 points to an average of $25.12 (low $18.69, high $36.38) — a potential gain of +65% on today's $15.25. Buyers look set to stay in control over this stretch.
In 2030, SMMT is projected to trade between $20.40 and $41.73, averaging $28.06 — a potential gain of +84% from today's $15.25. That is up +12% on the projected 2029 average. Momentum favours further upside here.
Summit Therapeutics Inc.'s 2031 outlook centres on $31.78, within a $22.61 to $48.36 range. That is up +13% on the projected 2030 average. That marks a +108% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SMMT could reach as high as $65.33, with a base case around $42.05 and support toward $29.34 — roughly +176% from $15.25. Momentum favours further upside here.
Expect SMMT to range from $33.24 to $76.82 through 2033. The $48.53 average target implies a +218% move from current prices. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SMMT price prediction for 2034 points to an average of $50.66 (low $34.09, high $81.57) — a potential gain of +232% on today's $15.25. Momentum favours further upside here.
In 2035, SMMT is projected to trade between $35.01 and $86.58, averaging $52.92 — a potential gain of +247% from today's $15.25. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Summit Therapeutics Inc.'s 2040 outlook centres on $95.05, within a $58.22 to $166.21 range. That is up +80% on the projected 2035 average. That marks a +523% change versus current levels. Momentum favours further upside here.
By 2050, SMMT could reach as high as $365.62, with a base case around $189.90 and support toward $101.63 — roughly +11.5x from $15.25. Buyers look set to stay in control over this stretch.
Investing $1,000 in SMMT today (≈ 65.57377 SMMT) could be worth
$12,452.37
+$11,452.37 (+1145%) by 2050 · US Dollar
Based on the average projected SMMT price of $189.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SMMTwould be worth at today's price.
$1,000 invested in SMMT on Jul 10, 2025 (≈ 38.639878 SMMT) would be worth
$589.26
-$410.74 (-41.1%) today · 0.59× · US Dollar
Based on a SMMT entry price of $25.88 vs. today's $15.25.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.42 | $988.98 | -1.1% |
| 1 month ago | $13.05 | $1,168.58 | +16.9% |
| 3 months ago | $19.67 | $775.29 | -22.5% |
| 6 months ago | $17.04 | $894.95 | -10.5% |
| 1 year ago | $25.88 | $589.26 | -41.1% |
| All time (5.0y) ago | $7.29 | $2,091.91 | +109.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SMMT forecast.
Our base-case forecast reaches $31.00 around 2031.
Implied market cap at $31.00: $24.06B
The long-term forecast shows a bullish trajectory across multiple years. In 2026 the forecast min is $13.05, the avg is $15.42, and the max is $21.16, with a neutral sentiment for that year.
By 2030 the forecast min is $20.12, avg $28.42, max $43.50, with ROI 84.3 and a bullish sentiment. By 2040 the forecast min is $56.15, avg $96.98, max $177.00, with ROI 528.9 and bullish sentiment. By 2050 the forecast min is $96.03, avg $195.31, max $395.45, with ROI 1166.6 and bullish sentiment.
These figures are estimates, not guarantees, and should be considered within the broader context of market conditions and execution risk.
Tap a question to reveal the answer.
2030 min $20.12; avg $28.42; max $43.50; ROI 84.3; sentiment BULLISH.
The forecast indicates strong upside over the long term, with 2030–2050 averages rising to $28.42, $96.98, and $195.31 respectively, and max values up to $43.50, $177.00, and $395.45. The sentiment is bullish in later years, but these are estimates, not guarantees.
Yes, the forecast for 2033 shows avg $50.35 with min $33.27 and max $82.49; ROI 226.5 and sentiment BULLISH.
2026 min $13.05; avg $15.42; max $21.16; ROI 0; sentiment NEUTRAL.
2040 min $56.15; avg $96.98; max $177.00; ROI 528.9; sentiment BULLISH.
Summit Therapeutics Inc. Community Discussion
0Share your Summit Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.